Bronxcare Health Systems, Chairman, Dr. Ira Kirschenbaum

Dr. Ira Kirshenbaum, Chairman at Bronxcare Health System, is an orthopedic surgeon by profession. His expertise as an orthopedic surgeon is notably unique due to his skills as a surgeon as well as an entrepreneur.

As a surgeon, Dr. Ira Kirschenbaum has applied his in depth entrepreneurial skills, corporate and non-profit experience to operations as a leader, using information technology, processing engineering, and innovative designs. Dr. Kirschenbaum has incorporated his talents in strategy execution, translation of complex data, information and ideas to offer advice, and educate key stakeholders in the medical healthcare industry.

Dr. Ira Kirschenbaum at Bronxcare Health System

He is the chairman at Bronxcare Health System since February 2008. The orthopedic department benefited greatly from his expertise as a surgeon and strategic planner. He has developed an entirely urban environment in the hospital, grown surgical services efficiency and enhanced outpatient service delivery system. With the greater New York having an approximate of 1.4 million patients expecting healthcare services, Dr. Ira Kirschenbaum developed a sustainable infrastructure and efficient structure of the organization to deliver the best care to patients.

His efforts have been recognized through awards and a recent patent for his innovative healthcare solutions, successful solutions, and services. Dr. Ira Kirschenbaum has published papers on the orthopedic field and is also a frequent public speaker, at international conferences and symposiums. His strengths lie in his characteristic ability to develop sustainable solutions, incorporate information technology and innovations in the development of successful healthcare delivery system.

Dr. Kirschenbaum’s experience

Before his position at Bronxcare Health system, Dr. Ira Kirschenbaum worked in different organizations such as Advisory Chief Technology Officer at Swiftpath Program, Managing Partner at Sprocket Health and Chief Medical Officer at DTC Healthcom. Others include Executive Advisory Board Member at Medscape, Medical Information Consultant at ICJR and Stryker, WebMD Expert Panel, and Blog Editor at WebMD, and, as Director of HER project team at American Academy of Orthopedic Surgeons.

Dr. Ira Kirschenbaum’s education

He studied Executive Education, Value Measurement in Healthcare at Harvard Business School, fellowship in Adult Reconstructive Surgery at Thomas Jefferson University, MD at Albert Einstein College, undergraduate degree at Brown University and Diploma at Far Rockaway High school.

Read more about Dr. Ira here https://en.everybodywiki.com/Dr._Ira_Kirschenbaum

“Marc Beer to guide LumeNXT as the board chairman “

LumeNXT is a new med-tech startup that is developing proprietary illumination technology. This technology is being used in making minimally invasive surgeries. With a promising technology, LumeNXT is expected to become a great med-tech company in coming days. They have now hired the services of Marc Beer, a notable name in the industry who has helped several startups to get global recognition as well as profitability in a very short time. What the company needs right now is an experienced leader who can guide its operations going forward. There is no better person to help the company than Marc Beer. He has been appointed the chairman of the board of LumeNXT, and now will guide the company as it targets to introduce a product line that will make it easier to perform surgeries with minimally invasive procedures.

LumeNXT was impressed by the track record of Marc Beer. He has managed to start and grow startups within a very short time. It is such track record that impressed LumeNXT who saw him as the best person to lead the company. He has been in similar situations many times and in all, he has come out victorious. Marc Beer is impressed by the illumination technology coming from this company because it will bring great efficiency and precision into the medical industry. The fact that visibility is enhanced makes it possible for doctors to perform minimally invasive procedures with far much better accuracy.

Marc Beer has over 25 years of experience in different fields of the healthcare industry. He has worked in pharmaceuticals, diagnostics, devices, biotechnology, and others. He has seen how startups come and collapse after a short time and have learned how to build strong businesses. It is very hard for medical startups to succeed, but Marc Beer has record success with all the startups he has guided.

Marc Beer at Renovia

Marc Beer is the co-founder and current CEO of Renovia Inc., a medtech startup based in Boston. He started this startup in 2016 and has since made significant efforts towards making it one of the best companies in the medical sector. Renovia is developing solutions for women affected by pelvic floor disorders. These are challenges that affect over 250 million women around the world. Learn more: https://www.linkedin.com/in/marcbeerRenovia Inc. has done pretty well as a company in the past two years. It has attracted leading investors in the healthcare industry such as the Longwood Fund. Investors see the idea as one that will succeed in the long run since we are in a baby boomer period where cases of pelvic floor disorders will continue to increase. LumeNXT is hoping to benefit from the exceptional leadership skills that Marc Beer possesses also to have a brighter future.

Nitin Khanna’s Successful Streak of Business Ventures

In the business world, nobody is born to become great. They must exhibit a long series of qualities that vary person to person. In order to make a name for yourself, having a unique charm is key. Nitin Khanna is an individual whose sense of market trends often places him ahead of the curve. He grew up in India with a family of hard workers. Throughout his childhood, he witnessed how an individual can grasp their future with hard work. This inspired him to study abroad at Purdue University when he turned 17. He recounts his story in a recent article with Digital Mode.

At Purdue University, Nitin Khanna studied Industrial Engineering. Upon completion of his masters, he felt the need to get his career started. Oracle Corporation hired him for various senior level positions. This was during a period of change for the business industry. He personally witnessed analog paper being replaced by computers for everyday transitions. This technological shift inspired him to create his own business. Nitin Khanna and his brother teamed up to run Saber Corporation. This was a company that would aid the technological shift in all industries. They helped private companies and government agencies alike upgrade their software. It was a major hit, but Nitin Khanna is always looking for the next opening.

By the end of the early 2000s, company mergers were happening across the business world. Nitin Khanna choose this as his next venture. He founded MergerTech in 2009 with the sole purpose of offering clients advice about their merger deals. This venture became very successful for him. The clients were satisfied, and his work become recognized on national level publications. Nitin Khanna’s most recent venture has been the cannabis industry. As more states legalize the drug, consumer demand is only rising. He established a business to lay the groundwork for an all in investment.

Nitin Khanna is the type of businessman who only looks forward. He never lingers in one industry for too long, before moving to the next thing to catch his attention. Nitin Khanna is mindful of the average consumers.

Read more about Khanna here https://blogwebpedia.com/portland-based-nitin-khanna.html

Marc Beer’s brilliance in the healthcare industry in a giant leap forward for women with pelvic floor disorders

A start-up company by the name of Renovia Inc. will be moving forward after closing a $32 million dollar deal with several new products for pelvic floor disorders. This new business deal also included a venture debt for $10 million dollars. This start-up company was co-founded by Marc Beer, a former Aegerion Pharmaceuticals CEO.

 

This med-tech company is based out of Boston. This company is developing a variety of therapeutic and diagnostic products to treat things such as urinary incontinence, a pelvic floor disorder that affects 250 million women globally. Leva was the Renovia Company’s first products. This product received FDA approval in the month of April.

A healthcare-focused investing firm that invested early on in the start-up company was the Longwood Fund. The Longwood Fund and Series B round was joined by the Missouri-Based Ascension Venture and the New York Based Perceptive Advisors. Their financial support with this business venture will go towards testing and developing several more diagnostic and therapeutic products, a new Leva product will be included.

 

Marc Beer stated that by combing proprietary and innovative form factors and sensor technologies with a healthcare digital platform would give their clients and/or customers valuable information to advise new options for treatments, understanding pelvic floor disorders, ultimately lower long-term costs for healthcare and drive greater knowledge. Beer stated that he and the company are thrilled with this leading healthcare investor group’s assistance that actually share their mission to treat, better diagnose and actually improve the millions off women’s lives who are affected with the disorders of the pelvic floor.

 

A response was not given by the company regarding its pipeline of products or its investments.

 

Marc Beer’s first business venture is Renovia since leaving Aegerion in the year of 2015. Beer brings over 25 years of commercialization and development in pharmaceuticals, biotechnology, diagnostics and devices. Beer and Ramon Iglesias MD as well as Yolanda Lorie founded Renovia in August 2016. All three successfully obtained financing for the closure of Series A with venture leading healthcare capital funds.

 

OvaScience (Nasdaq: OVAS) also has Beer serve as a strategic consultant. A business merger will also be taking place between Michigan-based Millendo Therapeutics and Waltham Biotech.

Learn more: https://renoviainc.com/